ArticleCardiac failure review2016
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure.
Article in Cardiac failure review, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.
- Guideline for Cardiovascular Magnetic Resonance Imaging from the Korean Society of Cardiovascular Imaging-Part 1: Standardized Protocol.Korean journal of radiology · 2019Guideline
- Diagnostic Tests for Stage B Heart Failure.Current cardiology reports · 2026Review
- From guidelines to radiology practice: navigating the 2023 ASCO guidelines for advanced gastroesophageal cancer and beyond.Abdominal radiology (New York) · 2025Review
- Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathy.Cardiovascular diabetology · 2024Article
- MRI Quantification of Cardiac Structure and Function in Cardiomyopathy Patients.Methods in molecular biology (Clifton, N.J.) · 2024Article
- Deep learning-based prognostic model using non-enhanced cardiac cine MRI for outcome prediction in patients with heart failure.European radiology · 2023Article
- Retrospective motion correction through multi-average k-space data elimination (REMAKE) for free-breathing cardiac cine imaging.Magnetic resonance in medicine · 2023Article
- Layer-specific strain in patients with cardiac amyloidosis using tissue tracking MR.Frontiers in radiology · 2023Article
- Defining Heart Failure Based on Imaging the Heart and Beyond.Cardiac failure review · 2023Review
- Review
- 30-minute CMR for common clinical indications: a Society for Cardiovascular Magnetic Resonance white paper.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2022Article
- Imaging in Women with Heart Failure: Sex-specific Characteristics and Current Challenges.Cardiac failure review · 2022Review
- A Late Diagnosis of Transthyretin Amyloidosis.Cureus · 2022Article
- The three-dimensional speckle tracking echocardiography in distinguishing between ischaemic and non-ischaemic aetiology of heart failure.ESC heart failure · 2020Article
- Should CMR be the default imaging modality in clinical trials for heart failure?Cardiovascular diagnosis and therapy · 2020Article
- Use of Cardiac Imaging to Evaluate Cardiac Function and Pulmonary Hemodynamics in Patients with Heart Failure.Current cardiology reports · 2019Review
- The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure.Cardiac failure review · 2017Article
- Residual Learning: A New Paradigm to Improve Deep Learning-Based Segmentation of the Left Ventricle in Magnetic Resonance Imaging Cardiac Images.Journal of medical signals and sensorsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Cardiovascular imaging is key for the assessment of patients with heart failure. Today, cardiovascular magnetic resonance imaging plays an established role in the assessment of patients with suspected and confirmed heart failure syndromes, in particular identifying aetiology. Its role in informing prognosis and guiding decisions around therapy are evolving. Key strengths include its accuracy; reproducibility; unrestricted field of view; lack of radiation; multiple abilities to characterise myocardial tissue, thrombus and scar; as well as unparalleled assessment of left and right ventricular volumes. T2* has an established role in the assessment and follow-up of iron overload cardiomyopathy and a role for T1 in specific therapies for cardiac amyloid and Anderson-Fabry disease is emerging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.